research Discovery and Optimization of Novel Pyridines as Highly Potent and Selective Glycogen Synthase Kinase 3 Inhibitors
New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.
Munich, Bayern, Germany
Poznań, Poland
Regina, SK, Canada
Tunis, Tunisia
Incomplete name
Dublin, Ireland
Addis Ababa, Ethiopia


